Citizen Petition from Alliance for Pharmacy Compounding
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Alliance for Pharmacy Compounding
- Posted
- Feb 5, 2026
- Comment period
- Feb 5, 2026 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jun 15, 2026Comment from Abbvie Inc.OpposeBusiness📎 Attachment
AbbVie Inc. opposes the Alliance for Pharmacy Compounding's petition, arguing that desiccated thyroid extract (DTE) products are biological products that must be licensed via the BLA pathway rather than being eligible for compounding. The company asserts that the classification of DTE as a biological product is a longstanding statutory requirement and urges the FDA to issue guidance prohibiting the illegal compounding of these products.
Read comment → - Jun 4, 2026Comment from LORANCE AMANDASupportIndividual
Amanda Lorance, a patient with a thyroid condition, supports the petition to prevent the FDA from reclassifying Desiccated Thyroid Extract (DTE) as a biological product. She argues that this reclassification would unfairly restrict access to customized, compounded formulations that are essential for her health and the health of other patients.
Read comment → - Feb 28, 2026Comment from Stephanie SandersSupportIndividual📎 Attachment
The commenter supports the petition to keep desiccated thyroid extract (DTE) available, arguing that it is safe, effective, and necessary for patients who do not respond well to synthetic hormones. They provide clinical evidence and personal testimony to counter the FDA's concerns regarding potency, safety, and efficacy.
Read comment →